FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386897000: Lamivudine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461075018 Lamivudine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481011010 Lamivudine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491831012 3TC en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461075018 Lamivudine (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461075018 Lamivudine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481011010 Lamivudine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481011010 Lamivudine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491831012 3TC en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
49891000195116 lamivudina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64071000195117 Lamivudin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235151000195114 3TC - Lamivudin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
819781000172111 lamivudine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
819781000172111 lamivudine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
49891000195116 lamivudina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64071000195117 Lamivudin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235151000195114 3TC - Lamivudin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine (substance) Is a Reverse transcriptase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Is a classe d'allergènes false Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Has disposition Reverse transcriptase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Is a Transferase inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Is a Pyrimidine true Inferred relationship Existential restriction modifier (core metadata concept)
Lamivudine (substance) Is a Nucleoside analogue true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Lamivudine and nevirapine and stavudine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Abacavir (as abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Abacavir (as abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz- and lamivudine- and tenofovir-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz and lamivudine and tenofovir only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz and lamivudine and tenofovir only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine 150 mg and stavudine 30 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Lamivudine 150 mg and stavudine 30 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Lamivudine 30 mg and zidovudine 60 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine 30 mg and zidovudine 60 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only dolutegravir and lamivudine and tenofovir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dolutegravir- and lamivudine- and tenofovir-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine- and tenofovir-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing lamivudine and tenofovir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine and tenofovir only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lamivudine and tenofovir only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

Start Page 2 of 2


This concept is not in any reference sets

Back to Start